Highlights of Catheterization and Cardiovascular Intervention CRT 2017

Slides:



Advertisements
Similar presentations
2013 ACCF/AHA/SCAI Update of the Clinical Competence Statement on Coronary Artery Interventional Procedures A Report of the American College of Cardiology.
Advertisements

Inequalities across Europe in access to primary angioplasty to treat acute heart attack patients -the cross-border dimension- John Martin, MD, FRCP, FESC,
Rate of Obstructive Coronary Disease in Elective Diagnostic Cath Manesh R. Patel, MD Assistant Professor of Medicine Director Cath Lab Research – Duke.
ARTS I & II Keith D Dawkins Southampton University Hospital.
CONTRAST AGENTS AND RADIOPHARMACEUTICALS IN CHILDREN WITH CARDIAC DISEASE: SHOULD THEIR USE BE STUDIED? John C. Ring, MD, FAAP, FACC Associate Professor.
The Structural Heart Disease Program your partners for advanced interventional cardiology Structural Heart Disease is a new branch of cardiology involving.
1 1 The Use of Percutaneous Coronary Intervention in Patients with Class I Indications for Coronary Artery Bypass Graft Surgery: Data from the National.
SCAAR UCR SWEDEN 2007 Stefan James, Jörg Carlsson, Johan Lindbäck, Tage Nilsson, Ulf Stenestrand, Lars Wallentin and Bo Lagerqvist for the SCAAR study.
Aspirin Resistance: Significance, Detection and Clinical Management of This Real Phenomenon Webcast May 10 th, 2004 Sponsored by.
Dissolvable Heart Stents Richard Melpignano. Coronary Heart Disease Coronary Heart Disease (CHD) is, as of 2012, the leading cause of death worldwide.
Bangalore S, et al. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA. 2012;308(13): ?
Internet Resources for Evidence-Based Practice Ben Skinner KnowledgeShare.
NCDR Registry Statistics End of 4th Quarter 2011 Registry # of Participants # of Patient Records # of Manuscripts/ Abstracts ACTION Registry®- GWTG TM.
: PROFI : A Prospective, Randomized Trial of Proximal Balloon Occlusion vs. Filter Embolic Protection in Patients Undergoing Carotid Stenting Klaudija.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease Developed in Collaboration with.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Cardiovascular Surgery J Am Coll Cardiol.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA guidelines for percutaneous coronary intervention.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Making Sense of Statistics in Clinical Trial Reports:
Durable Polymer DES: 5 Year Outcomes RESOLUTE Update Sigmund Silber, MD FESC, FACC, FAHA Heart Center at the Isar Munich, Germany On Behalf of the RESOLUTE.
Transradial Best Practices for Radial Access
TAVR in Patients With Chronic Kidney Disease
History in the Making: As soldiers returned from World War II, we had:
What Is a Mitral Center of Excellence?
CRT ACHIEVEMENT AWARD 20 YEARS
The Power of New Biomarkers to Detect Early Ischemia
5 Different Observational Datasets: Pros & Cons
Algorithm for preoperative management of patients taking antiplatelet therapy. ACS, acute coronary syndrome; BMS, bare metal stent; DES, drug-eluting stent;
PCI related in-hospital mortality based on race and gender in the USA
Carotid Artery Stenting Predictors of procedural and clinical success
CRT 2017 Interventional Challenging Case Anterior ST- Elevation Myocardial Infarction Resulting From Acute Occlusion of Left Internal Mammary Artery Graft.
Robert A. Guyton, MD  The Annals of Thoracic Surgery 
Figure 3 One-year adverse events (death, post-discharge myocardial infarction, revascularization) after PCI according to patients who (A) would not have.
Clinical need for determination of vulnerable plaques
Women, Bleeding, and Coronary Intervention
Successful CTO PCI Associated with Lower Mortality Risk
On-Site Surgical Back-up is ‘Critically’ Important for PCI!
Debate: What Does the Future Hold for the Treatment of Unprotected Left Main Disease? More PCI No More Routine Surgery Ron Waksman, MD, FACC Washington.
Publication Bias : How to Avoid it An Editor's View
How to Promote Women Awareness to Heart Disease and the Role for Women
The Hidden Cost of Underutilizing PCI for Chronic Total Occlusions
Catheter-Based Treatment of Coronary Artery Disease
Early strut coverage in patients receiving new-generation drug-eluting stents and its implications for dual antiplatelet therapy: a randomized clinical.
Glenn N. Levine et al. JACC 2016;68:
ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization  Manesh R. Patel, MD, FACC, Steven.
Duration of Dual Antiplatelet Therapy in Patients with an Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention  Chirag Bavishi, MD, MPH,
Cardiovacular Research Technologies
Percutaneous coronary invervention versus coronary artery bypass grafting: A meta- analysis  Yolba Smit, MD, MSc, Joan Vlayen, MD, Hetty Koppenaal, MD,
Glenn N. Levine et al. JACC 2016;68:
Robert A. Guyton, MD  The Annals of Thoracic Surgery 
2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease  Glenn N. Levine, MD, FACC, FAHA,
Peter K. Smith, MD  The Journal of Thoracic and Cardiovascular Surgery 
Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction  P.-G. Chassot, A. Delabays, D.R. Spahn 
NIPPON Trial design: Patients undergoing percutaneous coronary intervention were randomized to short-term dual antiplatelet therapy (DAPT) (6 months; n.
TRIAL HIGHLIGHT FROM ESC 2016: ACUTE CORONARY SYNDROMES
Effect of PCI on 1-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval (bars);
Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: An updated meta-analysis.
Why surgery won the SYNTAX trial and why it matters
European Society of Cardiology Scientific Congress, September 2006
Diffusion of new technology for the treatment of renovascular hypertension in the United States: Surgical revascularization versus catheter-based therapy,
Figure 1 Periprocedural myonecrosis and myocardial infarction after left main coronary artery revascularization with ... Figure 1 Periprocedural myonecrosis.
Recent Temporal Changes in Atherosclerotic Cardiovascular Diseases in Ontario: Clinical and Health Systems Impact  Jack V. Tu, MD, PhD, Anam M. Khan,
(A) Meta-analysis of repeat revascularisation in randomised trials.
Death, target vessel revascularisation (TVR) and myocardial infarction (MI) with bioresorbable vascular scaffold (BVS) versus drug-eluting stent (DES)
Markov model scheme. Markov model scheme. Patients start (state 0) with uncomplicated PCI revascularisation; then cycle between health states until death.
Clinical case report platform
A model of variation and accelerating factors in the process of acute care chain of patients with STEMI going for primary PCI. PCI, percutaneous coronary.
Effect of PCI on 3 to 5-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval.
The Clinical Significance and Management Implications of Chronic Total Occlusion Associated With Surgical Coronary Artery Revascularization  Lorenzo Azzalini,
P2Y12 receptor inhibitor therapy for secondary prevention of patients with stable coronary artery disease. P2Y12 receptor inhibitor therapy for secondary.
Presentation transcript:

Highlights of Catheterization and Cardiovascular Intervention CRT 2017 Steven R Bailey MD MSCAI, FACC, FACP Chair, Division of Cardiology Professor of Medicine and Radiology Janey Briscoe Distinguished Chair UT Health baileys@uthscsa.edu

Disclosure Statement of Financial Interest I, Steven R Bailey MD, DO have a financial interest/arrangement or affiliation with Wiley Publishing that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation.

Catheterization & Cardiovascular Diagnosis 42 Years Ago

Catheterization & Cardiovascular Diagnosis

Richard A. Lange, Anand Prasad Associate Editors S. Hinan Ahmed, Robert J. Chilton, Joaquin Cigarroa, Marvin H. Eng, Doff McElhinney, Marc D. Feldman, Richard A. Lange, Anand Prasad Section Editors Theodore A. Bass Helen P. Hazuda Ziyad M. Hijazi Morton J. Kern Valerie A. Lawrence Roxana Mehran John G. Webb

KEY RESULTS FOR Catheterization and Cardiovascular Interventions Reach & Readership Global Readership: 2015 Full Text Downloads by Region

CCI-ACTIVITY

2015 CCI Production Report Journal Section Total Accepted Rejected Withdrawn % Accepted Basic Science 7 2 5 28.6% Case Reports 661 90 571 1 13.6% Hemodynamic Rounds 50.0% Interventional Rounds 8 12.5% Clinical Decision Making 3 60.0% Original Studies 918 201 716 21.9% Total Refereed Manuscripts 1601 298 1302 18.6%

Most Downloaded Articles 2015 KEY RESULTS FOR Catheterization and Cardiovascular Interventions Reach and Readership: Wiley Online Library Statistics Most Downloaded Articles 2015 Rank Author(s) Article Title Volume Issue No. of Accesses 1 Schroeder, H., et al. Two-year results of a low-dose drug-coated balloon for revascularization of the femoropopliteal artery: Outcomes from the ILLUMENATE first-in-human study 86 2 1,063 Yamanaka, O., et al. Coronary artery anomalies in 126,595 patients undergoing coronary arteriography 21 1,016 3 SCAI Supplement: The Society for Cardiovascular Angiography and Interventions' 38th Annual Scientific Sessions 85 S2 845 4 Pandit, A., et al. Shorter (≤6 months) versus longer (≥12 months) duration dual antiplatelet therapy after drug eluting stents: A meta-analysis of randomized clinical trials 829 5 Rocha-Singh, K., et al. Peripheral arterial calcification: Prevalence, mechanism, detection, and clinical implications 83 6 726

2016 Editors Choice Articles CCI Editors Choice (November 2016): Liebregts et al Effect of alcohol dosage on long-term outcomes after alcohol septal ablation in patients with hypertrophic cardiomyopathy CCI Editors Choice (November 2016): Knot et al A hospital-wide system to ensure rapid treatment time across the entire spectrum of emergency percutaneous intervention CCI Editors Choice (September 2016): Pienda et al Completeness of revascularization and its impact on the outcomes of a staged approach of percutaneous coronary intervention followed by minimally invasive valve surgery for patients with concomitant coronary artery and valvular heart disease CCI Editor's Choice (August 2016): Ng et al Prognostic utility of myocardial blush grade after PCI in patients with NSTE-ACS: Analysis from the ACUITY trial CCI Editor's Choice (July 2016): Stetler et al Impact of crossing technique on the incidence of periprocedural myocardial infarction during chronic total occlusion percutaneous coronary intervention CCI Editor's Choice (June 2016): Szerlip et al The outcomes of transcatheter aortic valve replacement in a cohort of patients with end-stage renal disease

2016 Frank Hildner Elite Reviewer Emmanouil S. Brilakis, MD Jorge Belardi, MD James C. Blankenship, MD Emmanouil S. Brilakis, MD Ted E. Feldman, MD James A. Goldstein, MD Richard R. Heuser, MD Morton J. Kern, MD Roxana Mehran, MD Barry F. Uretsky, MD Ron Waksman, MD This plaque is presented in recognition of your expertise in providing constructive evaluations and critical comments which improve our knowledge and practice in the field of interventional cardiology. Your personal commitment and service is reflected in every issue of Catheterization and Cardiovascular Interventions and in the care we provide to our patients.

The Christopher J. White, MD Early Career Reviewer Award This plaque is presented in recognition of your expertise in providing constructive evaluations and critical comments which improve our knowledge and practice in the field of interventional cardiology.

Yes There Is An APP The Journal has its own App, available at the Apple App Store. SCAI members receive a 35% discount on ALL books at Wiley.com (membership code ‘SDP89’).